Century Therapeutics to Showcase Innovations at Healthcare Event
PHILADELPHIA, November 26, 2024 — Century Therapeutics (NASDAQ: IPSC), a pioneering biotechnology company, is set to participate in the upcoming Piper Sandler 36th Annual Healthcare Conference. This event, scheduled for December 4, will feature members from their management team discussing cutting-edge advancements in induced pluripotent stem cell (iPSC)-derived therapies.
Event Participation Details
As part of their participation at the conference, Century Therapeutics will be involved in two key events:
- Autoimmune Disease Cell Therapy Panel: Led by Chad Cowan, Ph.D., Chief Scientific Officer, this session is slated for 3:00 PM ET.
- Fireside Chat: Join Brent Pfeiffenberger, Pharm.D., Chief Executive Officer, and Chad Cowan, Ph.D., for an engaging discussion at 4:30 PM ET.
For those interested, a live webcast will be accessible on the 'Events & Presentations' page of Century Therapeutics' website, providing insights into the company's innovative approaches.
Understanding Century Therapeutics
Century Therapeutics is at the forefront of developing transformative cell therapy products. With a focus on cancer and autoimmune diseases, their work leverages the potential of adult stem cells to create curative therapies. Their genetically engineered iPSC-derived products are meticulously designed to target both hematologic and solid tumor cancers effectively.
Innovation in Therapy Development
The company is committed to overcoming the challenges associated with first-generation cell therapies. Their programs utilize advanced techniques in cellular reprogramming and genetic engineering. This ensures that their treatments not only meet the current medical needs but also provide hope for future therapeutic advancements.
The potential applications of these therapies extend beyond oncology; they also promise to address autoimmune disorders, expanding the horizon for patient care. By focusing on off-the-shelf solutions, Century Therapeutics aims to ensure wider availability of their innovative treatments.
Vision for the Future
Century Therapeutics understands the critical need for accessible therapies in today’s healthcare landscape. Their vision includes equal access to advanced treatments for patients battling severe diseases. Through their ongoing research and development efforts, they hope to set new standards in immuno-oncology and autoimmune disease management.
Company Contacts for Inquiries
If you wish to learn more about their initiatives or press inquiries, Century Therapeutics provides the following contact details:
Investor Relations & Media Contacts:
Katja Buhrer
SVP, Head of Corporate Affairs and Strategy
Email: katja.buhrer@centurytx.com
Phone: 917-969-3438
Noor Pahlavi
Email: century@argotpartners.com
Phone: 212-600-1902
Frequently Asked Questions
What is Century Therapeutics focusing on at the conference?
Century Therapeutics will discuss their advancements in iPSC-derived therapies for cancer and autoimmune diseases.
Who will represent Century Therapeutics at the event?
Chad Cowan, Ph.D. and Brent Pfeiffenberger, Pharm.D. will present at the event.
Where can I find more information about Century Therapeutics?
More information can be found on their official website under the 'Investors' section.
How is Century Therapeutics innovating cell therapies?
They utilize adult stem cells and advanced genetic techniques to develop therapies that address current limitations in treatment.
What are the future plans for Century Therapeutics?
The company aims to expand the availability and efficacy of their therapies for a larger patient population.
